Recor Medical, Inc.
Clinical trials sponsored by Recor Medical, Inc., explained in plain language.
Now part of
Otsuka Holdings Co., Ltd.
4578
TOKYO
Develops ultrasound-based renal denervation devices for hypertension.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device zaps kidney nerves to lower blood pressure in Real-World study Results expected Sep 2026 (estimated)